WuXi PharmaTech (Cayman) Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Sales revenue, services
Laboratory services
Manufacturing services
Total sales revenue, services
Cost of services
Laboratory services
Manufacturing services
Total cost of services
Gross profit
Laboratory services
Manufacturing services
Total gross profit
Operating (expenses) income
Selling and marketing expenses
General and administrative expenses
Research and development expenses
Impairment charges for goodwill and intangible assets
Revaluation of contingent consideration
Total operating expenses
Operating income
Investment income (loss)
Other income, net
Interest expense
Interest income
Income before income taxes
Income tax expense
Net income
Basic
Diluted
Earnings per share
Basic
Diluted
Other comprehensive income, net of tax:
Currency translation adjustments
Unrealized gains on available-for-sale securities
Unrealized loss on cash flow hedges
Subtotal
Comprehensive income
Shares used in calculating basic earnings per share
Shares used in calculating diluted earnings per share

Comments